Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page
- CheckyesterdayChange DetectedNew participating sites were added (CommonSpirit Saint Anthony Hospital Cancer Center; Saint Joseph Medical Center Hematology and Oncology - Silverdale) and existing sites (Saint Anthony Hospital; Saint Michael Cancer Center) were removed. The study now includes a Sample Collection procedure and the documentation updated to Revision: v3.5.5 with dates 2026-06-01 and 2027-05-15.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new page revision. The update likely reflects minor edits or fixes to the page content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page's revision tag updated from v3.5.2 to v3.5.3, indicating a newer version of the page content; this is a versioning update rather than a substantive change to the study details.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision history updated: added v3.5.2 with entries for 2026-04-09 and 2026-04-13, and removed entries for v3.5.0 dated 2026-04-07 and 2026-04-08.SummaryDifference0.1%

- Check59 days agoChange Detected- The study page history shows additions of 2026-04-07 and 2026-04-08 and deletions of 2026-03-31 and 2026-04-01, reflecting update history.SummaryDifference0.0%

- Check66 days agoChange DetectedTwo dates (2026-04-01 and 2026-03-31) were added and two dates (2026-03-24 and 2026-03-21) were removed from the Study Record Dates.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.